Tedeschi, Alessandra
 Distribuzione geografica
Continente #
AS - Asia 681
NA - Nord America 518
EU - Europa 450
SA - Sud America 126
AF - Africa 13
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.795
Nazione #
US - Stati Uniti d'America 490
SG - Singapore 349
IT - Italia 187
CN - Cina 171
BR - Brasile 106
SE - Svezia 91
IN - India 50
DE - Germania 38
IE - Irlanda 34
VN - Vietnam 27
ID - Indonesia 21
FR - Francia 20
GB - Regno Unito 17
FI - Finlandia 15
CA - Canada 14
MX - Messico 12
RU - Federazione Russa 11
AR - Argentina 10
JP - Giappone 10
KR - Corea 10
ES - Italia 9
IQ - Iraq 9
BD - Bangladesh 7
PL - Polonia 6
AT - Austria 5
HK - Hong Kong 5
IL - Israele 5
AU - Australia 4
UA - Ucraina 4
ZA - Sudafrica 4
AL - Albania 3
EG - Egitto 3
NL - Olanda 3
CZ - Repubblica Ceca 2
DZ - Algeria 2
EC - Ecuador 2
JO - Giordania 2
LB - Libano 2
LT - Lituania 2
MA - Marocco 2
NZ - Nuova Zelanda 2
OM - Oman 2
PK - Pakistan 2
SA - Arabia Saudita 2
TR - Turchia 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
BE - Belgio 1
BO - Bolivia 1
CH - Svizzera 1
CO - Colombia 1
EU - Europa 1
GT - Guatemala 1
GY - Guiana 1
IR - Iran 1
JM - Giamaica 1
KE - Kenya 1
KW - Kuwait 1
KZ - Kazakistan 1
NG - Nigeria 1
PE - Perù 1
PY - Paraguay 1
RS - Serbia 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 1.795
Città #
Singapore 208
Florence 73
Ashburn 69
Chandler 50
Beijing 49
New York 48
Hyderabad 39
Hefei 33
Dublin 32
Milan 22
Jakarta 20
Los Angeles 19
Dallas 17
São Paulo 15
Chicago 14
Rome 11
Frankfurt am Main 10
Kent 10
Seoul 10
Princeton 9
Tokyo 9
Wilmington 8
Ho Chi Minh City 7
San Mateo 7
Washington 7
Atlanta 6
Boston 6
Helsinki 6
London 6
Munich 6
Nuremberg 6
Phoenix 6
Turku 6
Dearborn 5
Denver 5
Moscow 5
Naples 5
Acerra 4
Benalla 4
Brooklyn 4
Düsseldorf 4
Hanoi 4
Hong Kong 4
Montreal 4
Pellezzano 4
Rio de Janeiro 4
Seattle 4
The Dalles 4
Asti 3
Baghdad 3
Brescia 3
Cairo 3
Haiphong 3
Johannesburg 3
Lappeenranta 3
Norwalk 3
Orem 3
Pune 3
Querétaro 3
San Jose 3
Santa Clara 3
Sesto Fiorentino 3
Vancouver 3
Verona 3
Agawam 2
Amman 2
Amsterdam 2
Bagheria 2
Belo Horizonte 2
Berzo Inferiore 2
Bremen 2
Bruino 2
Brusciano 2
Buffalo 2
Cattolica 2
Chennai 2
Erbil 2
Fairfield 2
Garden City 2
Gdansk 2
Guarulhos 2
Houston 2
Hải Dương 2
Juiz de Fora 2
Kunming 2
Lauterbourg 2
Londrina 2
Marcianise 2
Monteriggioni 2
Nasiriyah 2
Oklahoma City 2
Ottawa 2
Paris 2
Parma 2
Porto Alegre 2
Portsmouth 2
Pottstown 2
Quận Bình Thạnh 2
Roubaix 2
Salvador 2
Totale 1.028
Nome #
Preexisting and treatment-emergent autoimmune cytopenias in patients with CLL treated with targeted drugs 133
Diagnostic framing of IgM monoclonal gammopathy: Focus on Waldenström macroglobulinemia 105
Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: a GIMEMA, ERIC and UK CLL FORUM study 104
Prognostic impact and risk factors of infections in patients with chronic lymphocytic leukemia treated with ibrutinib 102
Zanubrutinib versus bendamustine and rituximab in untreated chronic lymphocytic leukaemia and small lymphocytic lymphoma (SEQUOIA): a randomised, controlled, phase 3 trial 96
Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real-world setting. A GIMEMA-ERIC and US study 93
Zanubrutinib monotherapy for patients with treatment-naïve chronic lymphocytic leukemia and 17p deletion 92
Coexisting conditions and concomitant medications do not affect venetoclax management and survival in chronic lymphocytic leukemia 85
Frontline treatment with the combination obinutuzumab ± chlorambucil for chronic lymphocytic leukemia outside clinical trials: Results of a multinational, multicenter study by ERIC and the Israeli CLL study group 85
Physicians’ misperceived cardiovascular risk and therapeutic inertia as determinants of low LDL-cholesterol targets achievement in diabetes 84
Ibrutinib dose intensity in high-risk chronic lymphocytic leukemia 80
COVID-19 in patients with Chronic Lymphocytic Leukemia treated with venetoclax: what is the role of anti-CD20 antibody? 80
Do age, fitness and concomitant medications influence management and outcomes of CLL patients treated with ibrutinib? 75
A scoring system to predict the risk of atrial fibrillation in chronic lymphocytic leukemia 71
Long-term benefit of IGHV mutated patients in a real-life multicenter cohort of FCR-treated chronic lymphocytic leukemia 69
Prediction of outcomes in chronic lymphocytic leukemia patients treated with ibrutinib: Validation of current prognostic models and development of a simplified three-factor model 69
How COVID-19 pandemic changed our attitude to venetoclax-based treatment in chronic lymphocytic leukemia 66
Ibrutinib in patients over 80 years old with CLL: a multicenter Italian cohort 64
Use of BTK inhibitors with special focus on ibrutinib in Waldenström macroglobulinemia: An expert panel opinion statement 62
Acalabrutinib in High-Risk Chronic Lymphocytic Leukaemia Naïve Patients: An Italian Multicenter Retrospective Observational Real-Life Experience 57
Use of BTK inhibitors with focus on ibrutinib in mantle cell lymphoma: An expert panel opinion statement 56
I complessi sacri e i culti di Praeneste tra l'età arcaica e l'età tardo repubblicana 50
Takotsubo syndrome after BNT162b2 mRNA Covid-19 vaccine: Emotional or causative relationship with vaccination? 17
Familial forms of chronic lymphocytic leukemia have a worse prognosis than sporadic forms: an Italian case-control study 15
Venetoclax-based regimens in octogenarian patients with CLL: efficacy, safety, and comparison to BTKi in a multicenter cohort 12
Totale 1.822
Categoria #
all - tutte 8.861
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.861


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213 0 0 0 0 0 1 0 0 1 0 1 0
2021/2022103 1 0 17 17 11 3 4 9 5 5 25 6
2022/2023194 30 23 14 11 11 22 3 12 24 8 32 4
2023/2024344 16 55 36 57 20 80 17 4 1 7 12 39
2024/2025444 8 4 37 8 52 22 10 16 31 73 115 68
2025/2026688 170 27 71 159 221 40 0 0 0 0 0 0
Totale 1.822